// App-Quantinova.ai

2279 : Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER.

Researchers

Presenter

  • Mariasanta Napolitano

Principal Investigators

  • Alberto Dolce

  • Marie Bertrand

  • Pimlak Charoenkwan

  • Dragan Micic

  • Maria Fernanda Lopez Fernandez

  • Arlette Ruiz de Saez

  • Sergio Siragusa

  • Jorgen Ingerslev

Medical Centers

  • Skejby University Hospital, Centre for Haemophilia and Thrombosis, Aarhus, Denmark

  • Department of Pediatrics, Division of Hematology, ChiangMai, Thailand

  • CHU Besancon, Besancon, France

  • Mother and Child Healthcare Institute of Serbia, Belgrade, Serbia

  • Hematology, Complejo Hospitalario Universitario Juan Canalejo, Sergas, Spain

  • Department of Biochimics, University of Ferrara, Rome, Italy

  • National Institute of Statistics, Palermo, Italy

  • Epidemology, University of Perugia, Perugia, Italy

  • National Haemophilia Centre, Banco Metropolitano de Sangre DC, Caracas, Venezuela, Caracas, Venezuela

  • Cattedra ed U.O. di Ematologia, Universita degli Studi di Palermo, Palermo, Italy,

Locations

  • Serbia

  • Italy

  • Spain

  • Venezuela

  • France

  • Thailand

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Superficial Vein Thrombosis

  • Factor VII deficiency

  • Hypertension

  • Venous thrombosis

Biomarkers

  • Prothrombin

Drug/Treatment

  • rFVIIa

  • Prothrombin complex

Outcome

  • N/A


Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim